
Andrew Chadeayne
@andrewchadeayne
CEO at CaaMTech
ID: 1442558052528361473
27-09-2021 18:33:58
67 Tweet
71 Followers
44 Following

Thank you Fast Company for highlighting our important work in #psychedelics as a part of "15 tech startups to watch in 2022." 👨🔬🧪 Read ✦Mr. Sullivan's piece here: fastcompany.com/90710812/15-te…



Psychedelic science opportunity🚨 We at Johns Hopkins Psychedelic Research Center are hiring a postdoc who will work with me & Roland Griffiths. Having gone through the postdoc program myself, I can vouch for the the excellent scientific training and wonderful people at the lab. Please share widely!


Our recent paper in Neuropsychopharmacology re SARs for cannabinoid-like effects of 5F-MDMB-PICA and 5F-pentylindole analogs in mice is featured as the NIDA IRP paper of the month 🙌😎 👇 irp.drugabuse.gov/featured-paper…





“It is an honor for us to carry on Dr. Alexander Shulgin’s legacy,” said Dr. Andrew Chadeayne, CEO of CaaMTech. “The current state of this industry is possible only because we’re standing on the shoulders of giants such as Alexander Shulgin.” caam.tech/caamtech-colla…

New paper by CaaMTech Marilyn Naeem Barb Bauer UMass Dartmouth Andrew Chadeayne! 4-HO-DiPT has been proposed as a more clinically-optimized alternative to #psilocybin #psychedelic #science #chemistry #crystallography caam.tech/caamtech-creat…





Psilacetin is More Potent than Psilocybin: CaaMTech, NIDAnews, Usona Institute, Ghent University Research, UMass Dartmouth and UWyo News researchers directly compared #psilocybin with understudied #magicmushroom molecules, and synthetic analogs such as psilacetin caam.tech/psilacetin-is-…




New pub out now in ACSChemNeurosci comparing 5-HT1A & 5-HT2A activities of #5MeODMT analogs #psychedelics pubs.acs.org/doi/full/10.10…
